MX2024007796A - Métodos y composiciones para mejorar el rendimiento en el ejercicio. - Google Patents

Métodos y composiciones para mejorar el rendimiento en el ejercicio.

Info

Publication number
MX2024007796A
MX2024007796A MX2024007796A MX2024007796A MX2024007796A MX 2024007796 A MX2024007796 A MX 2024007796A MX 2024007796 A MX2024007796 A MX 2024007796A MX 2024007796 A MX2024007796 A MX 2024007796A MX 2024007796 A MX2024007796 A MX 2024007796A
Authority
MX
Mexico
Prior art keywords
sub
fontan
exercise performance
patients
compositions
Prior art date
Application number
MX2024007796A
Other languages
English (en)
Spanish (es)
Inventor
James L Yeager
Original Assignee
Mezzion Pharma Co Ltd
James L Yeager
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mezzion Pharma Co Ltd, James L Yeager filed Critical Mezzion Pharma Co Ltd
Publication of MX2024007796A publication Critical patent/MX2024007796A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2024007796A 2021-12-20 2024-06-20 Métodos y composiciones para mejorar el rendimiento en el ejercicio. MX2024007796A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163291858P 2021-12-20 2021-12-20
PCT/US2022/000033 WO2023121689A1 (en) 2021-12-20 2022-12-20 Methods and compositions for improving exercise performance

Publications (1)

Publication Number Publication Date
MX2024007796A true MX2024007796A (es) 2025-04-02

Family

ID=85382567

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024007796A MX2024007796A (es) 2021-12-20 2024-06-20 Métodos y composiciones para mejorar el rendimiento en el ejercicio.

Country Status (8)

Country Link
US (1) US20240285630A1 (https=)
EP (1) EP4452273A1 (https=)
JP (1) JP2025504706A (https=)
CN (1) CN119072312A (https=)
AU (1) AU2022419178A1 (https=)
CA (1) CA3243958A1 (https=)
MX (1) MX2024007796A (https=)
WO (1) WO2023121689A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TN2017000029A1 (en) 2014-08-12 2018-07-04 Mezzion Pharma Co Ltd Methods of improving myocardial performance in fontan patients using udenafil compositions
AU2020356193A1 (en) * 2019-09-24 2022-05-19 Children's Hospital Of Philadelphia Methods of improving exercise performance, single ventricular performance, and myocardial performance index (MPI) in single ventricle heart disease, using udenafil compositions

Also Published As

Publication number Publication date
CA3243958A1 (en) 2023-06-29
EP4452273A1 (en) 2024-10-30
US20240285630A1 (en) 2024-08-29
JP2025504706A (ja) 2025-02-17
CN119072312A (zh) 2024-12-03
AU2022419178A1 (en) 2024-08-08
WO2023121689A1 (en) 2023-06-29

Similar Documents

Publication Publication Date Title
Terrados Altitude training and muscular metabolism
DE60107065D1 (de) Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
Chen et al. How to achieve a balanced and delicate lower third of the face in Orientals by mandibular contouring
NAMIAS et al. Tutnescent Anesthesia for Dermatologic Surgery: Cosmetic and Noncosmetic Procedures
Richards et al. Effect of hyperbaric oxygen therapy on the tubed pedicle flap survival in a rat model
Milton et al. The limited role of attenuated smallpox virus in the management of advanced malignant melanoma
Okka Hirudotherapy from past to present
WO2023003518A3 (en) Methods, compositions and kits for fat remodelling
MX2024001972A (es) Métodos y composiciones para tratar condiciones de hígado fibrótico, usando composiciones de udenafil
Plas et al. Complications of endoscopic thoracic sympathectomy
MX2024007796A (es) Métodos y composiciones para mejorar el rendimiento en el ejercicio.
MX2022003593A (es) Métodos para mejorar el rendimiento del ejercicio, el rendimiento ventricular único y el índice de rendimiento del miocardio (mpi) en la enfermedad cardiaca del ventrículo único, utilizando composiciones de udenafil.
JP2022550734A5 (https=)
Schwabegger et al. Refinements in pectus carinatum correction: the pectoralis muscle split technique
Hwang et al. Correction of facial linear scleroderma ‘coup de sabre’with BoneSource®
Ducic Fat grafting in trauma and reconstructive surgery
Martin et al. Self‐healing generalized infantile myofibromatosis
Hall et al. Porcine malignant hyperthermia. VIII: leg metabolism
Wever Fat Augmentation as adjunct to CORE facelift surgery
Echols High blood pressure and diabetes as stroke risk factors decrease in older populations
van Egmond et al. Perioperative pulmonary atelectasis: Comment
Pathansali et al. IST and CAST: some answers but more questions
Bostock et al. Challenging dogmas to enable progress forward
Simonenko et al. Thyroid disorders in recipients after heart transplantation